These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Early auditory-evoked potentials in body dysmorphic disorder: An ERP/sLORETA study. Giannopoulos AE; Zioga I; Papageorgiou PC; Kapsali F; Spantideas ST; Kapsalis NC; Capsalis CN; Kontoangelos K; Papageorgiou CC Psychiatry Res; 2021 May; 299():113865. PubMed ID: 33735739 [TBL] [Abstract][Full Text] [Related]
3. Instantaneous radiated power of brain activity: application to prepulse inhibition and facilitation for body dysmorphic disorder. Giannopoulos AE; Spantideas ST; Capsalis C; Papageorgiou P; Kapsalis N; Kontoangelos K; Papageorgiou C Biomed Eng Online; 2021 Oct; 20(1):108. PubMed ID: 34689781 [TBL] [Abstract][Full Text] [Related]
4. Yale-Brown Obsessive Compulsive Scale modified for Body Dysmorphic Disorder (BDD-YBOCS): Brazilian Portuguese translation, cultural adaptation and validation. de Brito MJ; Sabino Neto M; de Oliveira MF; Cordás TA; Duarte LS; Rosella MF; Felix GA; Ferreira LM Braz J Psychiatry; 2015; 37(4):310-6. PubMed ID: 26692429 [TBL] [Abstract][Full Text] [Related]
5. Reliability and Validity of the Self-Report Version of the Yale-Brown Obsessive-Compulsive Scale Modified for Body Dysmorphic Disorder. Patel TA; Summers BJ; Wilver NL; Cougle JR Assessment; 2023 Sep; 30(6):1935-1946. PubMed ID: 36114713 [TBL] [Abstract][Full Text] [Related]
6. Test-retest reliability of brain oscillations in a prepulse inhibition and facilitation paradigm: effects of gender in healthy humans. Stachtea X; Zioga I; Giannopoulos AE; Papageorgiou PC; Spantideas ST; Kapsalis NC; Capsalis CN; Papageorgiou CC Neuroreport; 2020 Sep; 31(13):985-990. PubMed ID: 32694313 [TBL] [Abstract][Full Text] [Related]
7. Degree connectivity in body dysmorphic disorder and relationships with obsessive and compulsive symptoms. Beucke JC; Sepulcre J; Buhlmann U; Kathmann N; Moody T; Feusner JD Eur Neuropsychopharmacol; 2016 Oct; 26(10):1657-66. PubMed ID: 27514293 [TBL] [Abstract][Full Text] [Related]
8. Therapist guided internet based cognitive behavioural therapy for body dysmorphic disorder: single blind randomised controlled trial. Enander J; Andersson E; Mataix-Cols D; Lichtenstein L; Alström K; Andersson G; Ljótsson B; Rück C BMJ; 2016 Feb; 352():i241. PubMed ID: 26837684 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of cognitive behaviour therapy versus anxiety management for body dysmorphic disorder: a randomised controlled trial. Veale D; Anson M; Miles S; Pieta M; Costa A; Ellison N Psychother Psychosom; 2014; 83(6):341-53. PubMed ID: 25323062 [TBL] [Abstract][Full Text] [Related]
10. Face and Object Perception in Body Dysmorphic Disorder versus Obsessive-Compulsive Disorder: The Mooney Faces Task. Toh WL; Castle DJ; Rossell SL J Int Neuropsychol Soc; 2017 Jul; 23(6):471-480. PubMed ID: 28528596 [TBL] [Abstract][Full Text] [Related]
11. Attentional biases in body dysmorphic disorder (BDD): Eye-tracking using the emotional Stroop task. Toh WL; Castle DJ; Rossell SL Compr Psychiatry; 2017 Apr; 74():151-161. PubMed ID: 28167328 [TBL] [Abstract][Full Text] [Related]
12. Insight in body dysmorphic disorder (BDD) relative to obsessive-compulsive disorder (OCD) and psychotic disorders: Revisiting this issue in light of DSM-5. Toh WL; Castle DJ; Mountjoy RL; Buchanan B; Farhall J; Rossell SL Compr Psychiatry; 2017 Aug; 77():100-108. PubMed ID: 28651226 [TBL] [Abstract][Full Text] [Related]
13. How individuals with body dysmorphic disorder (BDD) process their own face: a quantitative and qualitative investigation based on an eye-tracking paradigm. Toh WL; Castle DJ; Rossell SL Cogn Neuropsychiatry; 2017 May; 22(3):213-232. PubMed ID: 28322616 [TBL] [Abstract][Full Text] [Related]
14. Body dysmorphic disorder in patients with obsessive-compulsive disorder: prevalence and clinical correlates. Conceição Costa DL; Chagas Assunção M; Arzeno Ferrão Y; Archetti Conrado L; Hajaj Gonzalez C; Franklin Fontenelle L; Fossaluza V; Constantino Miguel E; Rodrigues Torres A; Gedanke Shavitt R Depress Anxiety; 2012 Nov; 29(11):966-75. PubMed ID: 22815241 [TBL] [Abstract][Full Text] [Related]
15. Visual selective attention in body dysmorphic disorder, bulimia nervosa and healthy controls. Kollei I; Horndasch S; Erim Y; Martin A J Psychosom Res; 2017 Jan; 92():26-33. PubMed ID: 27998509 [TBL] [Abstract][Full Text] [Related]
16. Cognitive dysfunction in body dysmorphic disorder: new implications for nosological systems and neurobiological models. Jefferies-Sewell K; Chamberlain SR; Fineberg NA; Laws KR CNS Spectr; 2017 Feb; 22(1):51-60. PubMed ID: 27899165 [TBL] [Abstract][Full Text] [Related]
17. Seeing in the Mind's eye: Imagery rescripting for patients with body dysmorphic disorder. A single case series. Ritter V; Stangier U J Behav Ther Exp Psychiatry; 2016 Mar; 50():187-95. PubMed ID: 26298841 [TBL] [Abstract][Full Text] [Related]
18. Unravelling brain connectivity patterns in body dysmorphic disorder during decision-making on visual illusions: A graph theoretical approach. Giannopoulos AE; Zioga I; Luft CDB; Papageorgiou P; Papageorgiou GN; Kapsali F; Kontoangelos K; Capsalis CN; Papageorgiou C Psychiatry Res; 2023 Jul; 325():115256. PubMed ID: 37216795 [TBL] [Abstract][Full Text] [Related]
19. The Dysmorphic Concern Questionnaire: A screening measure for body dysmorphic disorder. Mancuso SG; Knoesen NP; Castle DJ Aust N Z J Psychiatry; 2010 Jun; 44(6):535-42. PubMed ID: 20397781 [TBL] [Abstract][Full Text] [Related]
20. Empirically defining treatment response and remission in body dysmorphic disorder. Fernández de la Cruz L; Enander J; Rück C; Wilhelm S; Phillips KA; Steketee G; Sarvode Mothi S; Krebs G; Bowyer L; Monzani B; Veale D; Mataix-Cols D Psychol Med; 2021 Jan; 51(1):83-89. PubMed ID: 31662124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]